Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Buyback announced
Acq. announced
OMNICELL, INC. (OMCL) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2023 8-K Quarterly results
Docs: "Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results",
"Investor Relations"
08/04/2022 8-K Quarterly results
04/28/2022 8-K Quarterly results
Docs: "Omnicell Announces Financial Results for First Quarter 2022"
02/14/2022 8-K Quarterly results
Docs: "Omnicell Reports Fiscal Year and Fourth Quarter 2021 Results"
11/02/2021 8-K Quarterly results
Docs: "Omnicell Announces Financial Results for Third Quarter 2021"
07/29/2021 8-K Quarterly results
Docs: "Omnicell Announces Financial Results for Second Quarter 2021"
02/01/2021 8-K Quarterly results
10/27/2020 8-K Quarterly results
Docs: "Omnicell Reports Third Quarter 2020 Results GAAP and non-GAAP revenues of $213.7 million GAAP net income per diluted share of $0.20"
07/28/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
02/06/2020 8-K Quarterly results
Docs: "Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43"
10/24/2019 8-K Quarterly results
07/25/2019 8-K Quarterly results
Docs: "Omnicell Reports Results for Second Quarter 2019 Record GAAP and non-GAAP revenues of $217.4 million, up 15.2% year-over-year GAAP net income per diluted share of $0.37, up 131.3% year-over-year Non-GAAP net income per diluted share of $0.67, up 45.7% year-over-year MOUNTAIN VIEW, Calif. -- -- Omnicell, Inc. , a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2019. GAAP Results GAAP revenues for the second quarter of 2019 were $217.4 million, up $28.7 million, or 15.2% from the second quarter of 2018. GAAP revenues for the six months ended June 30, 2019 were $419.9 million, up $48.6 million, or 13.1%, from the six months ended June 30, 2018. Second quarter 2019 GAAP ..."
04/25/2019 8-K Quarterly results
Docs: "Omnicell Reports Results for First Quarter 2019 GAAP and non-GAAP revenues of $202.5 million, up 10.9% year-over-year GAAP net income per diluted share of $0.08, up 14.3% year-over-year Non-GAAP net income per diluted share of $0.61, up 110.3% year-over-year"
02/07/2019 8-K Quarterly results
10/25/2018 8-K Quarterly results
Docs: "Omnicell Achieves Record Revenue in the Third Quarter 2018 GAAP revenues of $204 million, up 9.4% year-over-year GAAP net income per diluted share of $0.33, up 65% year-over-year Non-GAAP revenues of $204 million, up 9.2% year-over-year Non-GAAP net income per diluted share of $0.63, up 37% year-over-year"
07/26/2018 8-K Quarterly results
Docs: "Omnicell Announces Second Quarter 2018 Results GAAP revenues of $189 million, up 4.2% year-over-year GAAP net income per diluted share of $0.16, up $0.11 year-over-year Non-GAAP revenues of $189 million, up 4.0% year-over-year Non-GAAP net income per diluted share of $0.46, up $0.13 year-over-year"
04/26/2018 8-K Quarterly results
Docs: "Omnicell Announces First Quarter 2018 Results GAAP revenue of $183 million, up 23% year-over-year GAAP net income per diluted share of $0.07, up $0.35 year-over-year Non-GAAP revenue of $183 million, up 23% year-over-year Non-GAAP net income per diluted share of $0.29, up $0.22 year-over-year"
02/01/2018 8-K Quarterly results
Docs: "Omnicell Reports Results for Fiscal Year and Fourth Quarter 2017 Record yearly GAAP revenue of $716.2 million Record yearly Non-GAAP revenue of $717.4 million 2017 GAAP net income per diluted share of $0.53 2017 Non-GAAP net income per diluted share of $1.33 Record ending product backlog of $345 million"
10/26/2017 8-K Quarterly results
07/27/2017 8-K Quarterly results
Docs: "Omnicell Achieves Record Revenue in the Second Quarter 2017 GAAP revenue of $180.9 million and GAAP net income per diluted share of $0.02 Non-GAAP revenue of $181.2 million and non-GAAP net income per diluted share of $0.31"
05/04/2017 8-K Form 8-K - Current report
02/15/2017 8-K Form 8-K - Current report
10/27/2016 8-K Form 8-K - Current report
07/28/2016 8-K Quarterly results
Docs: "Omnicell Achieves Record Revenue in the Second Quarter 2016 Record GAAP revenue of $172.9 million representing 53% year over year growth Record Non-GAAP revenue of $175.6 million representing 56% year over year growth Integration of Aesynt progressing as planned and well received by our customers"
10/31/2013 8-K Quarterly results
Docs: "Omnicell Announces Third Quarter 2013 Results"
08/01/2013 8-K Quarterly results
Docs: "Omnicell Announces Second Quarter 2013 Results"
05/02/2013 8-K Quarterly results
Docs: "Omnicell Announces First Quarter 2013 Results"
10/25/2012 8-K Quarterly results
Docs: "Omnicell Announces Record Revenue and Profit in Third Quarter 2012"
08/01/2012 8-K Quarterly results
Docs: "Omnicell Announces Second Quarter 2012 Results"
05/02/2012 8-K Quarterly results
Docs: "Omnicell Announces First Quarter 2012 Results"
01/26/2012 8-K Form 8-K - Current report
10/27/2011 8-K Form 8-K - Current report
07/28/2011 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy